Pravastatin 80 mg Tablets Dosed in Healthy Subjects Under Non-Fasting Conditions
Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
This study compared the relative bioavailability (rate and extent of absorption) of
Pravastatin Sodium Tablets 80 mg by Teva Pharmaceutical Industries, Ltd. with that of
Pravachol® Tablets 80 mg by Bristol-Myers Squibb Company following a single oral dose (1 x 80
mg tablet)in healthy adult male subjects administered under non-fasting conditions.